Počet záznamov: 1
atorvastatín
SYS d000069059 LBL 00000cz--a2200181n--4500 005 20250606221742.3 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D03.383.129.578.075 065 $a D10.251.450.200 066 $a 01 $c 03 150 $a atorvastatín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a atorvastatín kalcium bezvodý $2 slo 450 $w v $a atorvastatín kalcium hydrát $2 slo 450 $w v $a atorvastatín kalcium trihydrát $2 slo 450 $w v $a atorvastatín, vápenatá soľ $2 slo 450 $w v $a atorvastatín kalcium $2 slo 450 $w v $a atorvastatín $2 slo 450 $w v $a CI 981 $2 slo 450 $w v $a Lipitor $2 slo 450 $w v $a Liptonorm $2 slo 550 $7 sllk_us_auth*d000924 $Y Anticholesteremic Agents $w P $a anticholesterolemiká 550 $7 sllk_us_auth*d019161 $Y Hydroxymethylglutaryl-CoA Reductase Inhibitors $w P $a inhibítory hydroxymetylglutaryl-CoA-reduktázy 665 $a 2019 (1990) $2 eng 680 9-
$i A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. $2 eng 750 -2
$a Atorvastatin $2 eng 980 $x M
Počet záznamov: 1